AXGN
Axogen IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$2.17B
P/E Ratio
—
EPS
$-0.64
Beta
1.17
52W High
$45.83
52W Low
$9.22
50-Day MA
$37.02
200-Day MA
$28.00
Dividend Yield
—
Profit Margin
-13.20%
Forward P/E
357.14
PEG Ratio
99.04
About Axogen Inc
AxoGen, Inc., develops and markets surgical solutions for physical damage or transection of peripheral nerves. The company is headquartered in Alachua, Florida.
Fundamentals
| Revenue (TTM) | $238.10M |
| Gross Profit (TTM) | $178.61M |
| EBITDA | $-2.13M |
| Operating Margin | -4.61% |
| Return on Equity | -18.00% |
| Return on Assets | -2.32% |
| Revenue/Share (TTM) | $5.00 |
| Book Value | $4.61 |
| Price-to-Book | 8.88 |
| Price-to-Sales (TTM) | 9.13 |
| EV/Revenue | 8.79 |
| EV/EBITDA | 4083.53 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 26.60% |
| Shares Outstanding | $53.18M |
| Float | $51.90M |
| % Insiders | 2.10% |
| % Institutions | 94.63% |
Historical Volatility
HV 10-Day
30.89%
HV 20-Day
37.48%
HV 30-Day
45.34%
HV 60-Day
51.16%
HV Rank
22.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($50.78 target)
2
Strong Buy7
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026